Document is current
Any future updates will be listed below
-
Authors
Liu, Qianli
Helmin, Kathryn A.
Bailey, Jeanette C.
Pérez-Leonor, Xóchitl G.
Phan, Duc
Abdala-Valencia, Hiam
Mithal, Leena B.
Singer, Benjamin D.
Robbins, Mary E.
Perez, Marta
-
Funding
Funding for this research was provided by:
David W. Cugell Fellowship
Northwestern University Genomics Network (GeNe) Pilot Project Funding
National Heart, Lung, and Blood Institute (R01HL149883)
National Institute on Aging (P01AG049665)
National Institute of Allergy and Infectious Diseases (U19AI135964)
- License Information
-
More Information
Article History
Received: 6 November 2025
Accepted: 11 May 2026
First Online: 15 May 2026
Declarations
Ethics statement: All patients were enrolled in the Prentice Birth Cohort within the NUCord biorepository under Northwestern University IRB (STU00201858) and Lurie Children’s Hospital IRB (2018–2145). The study was approved by the Institutional Review Board at Northwestern University and at Lurie Children’s Hospital. Maternal informed consent was obtained before participation for use of clinical data and cord blood samples, including for isolation of DNA/RNA for genomic and sequencing studies. All research activities were performed in accordance with the Declaration of Helsinki.
Competing interests: BDS holds United States Patent No. US 10,905,706 B2, Compositions and Methods to Accelerate Resolution of Acute Lung Inflammation, and serves on the Scientific Advisory Board of Zoe Biosciences. The other authors have no competing interests to declare.
